Potentiating of lipid-lowering activity of clofibrate by combining with low doses of 3-pyridylcarbinol in rats
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference14 articles.
1. The combined use of CPIB and thyroxine in treatment of hyperlipoproteinemias;Strisower;Circulation,1966
2. Treatment of essential hypercholesterolemia with clofibrate and nicotinic acid;Nordøy;Acta Med. Scand.,1970
3. Reduction of serum cholesterol and triglyceride levels by the combined administration of neomycin and clofibrate;Samuel;Circulation,1970
4. Cholestyramine and nicotinic acid in the treatment of familial hyperbetalipoproteinema in the homozygous form;Mountafis;Atherosclerosis,1971
5. Treatment of hyperlipidemia: The rationale for combinations of lipid lowering drugs;Parsons;Intern. Med. Digest.,1971
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pharmacokinetics and hypolipidemic activity of clofibrate-nicotinic acid combinations in rats;Biochemical Pharmacology;1979-04
2. Hypocholesterolaemia in the rat after acid (CPIB) administration as a synthetic triglyceride, 1,3-dipalmitoyl;Clinica Chimica Acta;1977-09
3. Influence of etofibrate on plasma fibrinogen and plasminogen concentrations in patients with different forms of primary hyperlipoproteinemia;Atherosclerosis;1976-11
4. Zur Frage des Typenwandels bei Hyperlipoproteinaemie (Typ IIb, IV, V) unter der Therapie mit Clofibrat und m-Inositolnicotinat;Verhandlungen der Deutschen Gesellschaft für innere Medizin;1976
5. Hypolipidaemic aryloxyacetic acids;Medicinal Chemistry
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3